Inhibitory mechanism of taurine against CCi4 induced hepatic fibrosis in rats
梁健,杨光业,张锡流,庞玉生,袁海锋,梁劲松,黄仁彬,韦新,韦明
DOI: https://doi.org/10.3969/j.issn.1009-3079.2003.09.034
2003-01-01
World Chinese Journal of Digestology
Abstract:AIM: To study the protective effect of taurine on hepatic fibrosis induced by carbon tetrachloride (CCl4) in rats and its mechanisms. METHODS: CCl4-induced rat hepatic fibrosis was treated by taurine (400 and 800 mg/kg per day for 12 weeks), and serum alanine aminotransferase (ALT), plasma protein, hyaluronic acid (HA) and procollagen (PC ), and hepatic hydroxyproline (HYP), hepatic microsomal drug-metaboliz- ing enzyme and anti-transforming growth factor β1 (TGF-β1) were measured. In addition, pathological changes of liver tissue were observed by light microscope. RESULTS: The hepatic fibrosis, activity of serum ALT (2 601±300 1367±317 nkat/L, P <0.01), and contents of serum HA (324±95 219±79 μg/L, P <0.01), PC (33±14 19±8 mg/L, P <0.01) and hepatic HYP (1 282±523 381±147 μg/L, P <0.01) were markedly reduced by the treatment with taurine (32.57±13.73 vs 19.20±8.25 ng/ml, P <0.01 and 1.282±0.523 vs 0.463±0.159 μg/ml, P <0.05). The contents of plasma albumin (23±3 31±4 g/L, P <0.05) and hepatic cytochrome P450(Cyt.P450)(211±27 811±136 nmol/g, P <0.01) and cytochrome b5 (Cyt.b5) (256±69 761±131 nmol/g, P <0.01) were increased by the same treatment (0.211±0.027 vs 0.765±0.106 nmol/mg protein, P <0.01 and 0.256±0.069 vs 0.697±0.120 nmol/mg protein, P <0.01). In addition, taurine could also significantly inhibit the expression of TGF-β1 (33±13 20±6 , P <0.01). CONCLUSION: CCl4-induced hepatic fibrosis is markedly relieved by the treatment of taurine, and its protective mechanisms are related to the decrease in liver injury and expression of TGF-β1.